| Hazard Information | Back Directory | [Uses]
Bevasiranib is a siRNA designed to silence the genes that produce vascular endothelial growth factor (VEGF). It is widely accepted that vascular endothelial growth factor (VEGF) is a key component in the pathogenesis of choroidal neo-vascularization (CNV), which is a precursor to wet age-related macular degeneration (wet AMD). | [References]
[1] Garba AO, Mousa SA. Bevasiranib for the treatment of wet, age-related macular degeneration.?Ophthalmol Eye Dis. 2010;2:75-83. DOI:10.4137/OED.S4878 [2] Dejneka NS, Wan S, Bond OS, Kornbrust DJ, Reich SJ. Ocular biodistribution of bevasiranib following a single intravitreal injection to rabbit eyes.?Mol Vis. 2008;14:997-1005. PMID:18523657 |
|
|